Anlotinib in Metastatic HER2 Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm|Antineoplastic Agents|Anlotinib
Interventions: DRUG: Anlotinib Hydrochloride
Sponsor: Peng Yuan